Insmed | INSM - Loan Capital

Stock Price
153.02
Daily Change
1.99 1.32%
Monthly
-13.06%
Yearly
91.39%
Q1 Forecast
152.04

Insmed reported $539.72M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
BioMarin Pharmaceutical USD 596.66M 501K Sep/2025
Cytokinetics USD 158.75M 554.3M Sep/2025
DBV Technologies USD 0 0 Mar/2025
Dynavax Technologies USD 220.97M 214K Sep/2025
Gilead Sciences USD 22.14B 5M Sep/2025
Insmed USD 539.72M 21.23M Sep/2025
Novartis USD 24.24B 174M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Sarepta Therapeutics USD 1.04B 104.31M Sep/2025
Ultragenyx Pharmaceutical USD 782.75M 11.3M Jun/2025
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025